| 摘要 |
<p>As preparations having a high absorbability via the digestive tract and an excellent stability, it is intended to provide preparations which contain: (1) a compound having an antiallergic, antihistamine, anti-inflammatory, anti-PAF and/or eosinophil chemotaxis inhibitory effects (in particular, a basic or dipolar compound having an antiallergic, antihistamine, anti-inflammatory, anti-PAF and/or eosinophil chemotaxis inhibitory effects); and (2) an acidic compound.</p> |
